Exploring Novartis’ Interest in Medtech

Reza Zadno, PhD, EIR at InterWest Partners explains his new role at the Novartis Venture Fund. He’ll advise the pharma company on where to commit its considerable dollars in Medtech. Novartis, which own Alcon, historically has invested in Medtech and has done a nice job investing in companies like Zadno’s Visiogen.

Speaking With:

Reza Zadno

Reza Zadno

Reza is a serial entrepreneur and investor who joined InterWest in 2012. As a successful ophthalmology and cardiology executive, he has a special interest in medical devices.

View Full Profile